Baseline Differences in Driving Frequency as a Predictor of Cognitive Decline and Alzheimer's Disease

被引:0
|
作者
Miller, Luke R. [1 ,2 ,3 ,4 ]
Reed, Christopher [1 ,2 ]
Divers, Ross [1 ,2 ]
Calamia, Matthew [1 ,2 ]
机构
[1] Louisiana State Univ, Dept Psychol, Baton Rouge, LA USA
[2] Agr & Mech Coll, Baton Rouge, LA USA
[3] Louisiana State Univ, Psychol Dept, 115 Audubon Hall, Baton Rouge, LA 70803 USA
[4] Agr & Mech Coll, 115 Audubon Hall, Baton Rouge, LA 70803 USA
关键词
daily driving frequency; objective cognitive decline; Alzheimer's disease; older adults; LIFE SPACE; INSTRUMENTAL ACTIVITIES; PHYSICAL-ACTIVITY; OLDER PERSONS; RUSH MEMORY; PERFORMANCE; CESSATION; IMPAIRMENT; COMMUNITY; DEMENTIA;
D O I
10.1177/08919887231175436
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective To extend prior research by examining daily driving frequency as a predictor of cognitive decline and later diagnosis of Alzheimer's disease. Methods 1,426 older adults completed batteries of questionnaires and neuropsychological tests at baseline and yearly follow-ups (M = 6.8, SD = 4.9). Linear mixed effects models were estimated to examine whether daily driving frequency at baseline was predictive of cognitive decline while accounting for IADLs, mobility, depression, and demographics. Cox regression was used to examine driving frequency as a predictor of Alzheimer's disease diagnosis. Results Less daily driving frequency was associated with greater decline in all cognitive domains over time except for working memory. Although driving frequency was associated with these changes in cognition, it did not uniquely predict the development of Alzheimer's disease when accounting for other factors (eg, other IADLs). Conclusions Our findings extend prior research linking driving cessation to greater levels of cognitive decline. Future work might benefit from examining the utility of driving habits (especially changes in driving) as measures of everyday functioning in older adult evaluations.
引用
收藏
页码:14 / 23
页数:10
相关论文
共 50 条
  • [41] Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
    Lim, Nicholas S.
    Swanson, Christine R.
    Cherng, Hua-Ren
    Unger, Travis L.
    Xie, Sharon X.
    Weintraub, Daniel
    Marek, Ken
    Stern, Matthew B.
    Siderowf, Andrew
    Trojanowski, John Q.
    Chen-Plotkin, Alice S.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05): : 346 - 355
  • [42] Psychometric Cognitive Decline Precedes the Advent of Subjective Cognitive Decline in the Evolution of Alzheimer's Disease
    Reisberg, Barry
    Shao, Yongzhao
    Moosavi, Mesum
    Kenowsky, Sunnie
    Vedvyas, Alok
    Marsh, Karyn
    Bao, Jia
    Buj, Maja
    Torossian, Carol
    Kluger, Alan
    Vedvyas, Gaurav
    Oo, Thet
    Malik, Fawad
    Arain, Fauzia
    Masurkar, Arjun, V
    Wisniewski, Thomas
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2020, 49 (01) : 16 - 21
  • [43] Baseline predictor of clinical progression and longitudinal change of cognitive performance among patients with early Alzheimer's disease
    Yoon, G. J.
    Shin, C. -S.
    Choi, S. -M.
    Shin, B. -S.
    Kim, J. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 557 - 557
  • [44] Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer's Disease
    Tahmasebi, R.
    Zehetmayer, S.
    Stoegmann, E.
    Lehrner, Johann
    CHEMOSENSORY PERCEPTION, 2020, 13 (01) : 59 - 70
  • [45] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [46] Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
    Wang, Qing
    Chen, Gengsheng
    Schindler, Suzanne E.
    Christensen, Jon
    McKay, Nicole S.
    Liu, Jingxia
    Wang, Sicheng
    Sun, Zhexian
    Hassenstab, Jason
    Su, Yi
    Flores, Shaney
    Hornbeck, Russ
    Cash, Lisa
    Cruchaga, Carlos
    Fagan, Anne M.
    Tu, Zhude
    Morris, John C.
    Mintun, Mark A.
    Wang, Yong
    Benzinger, Tammie L. S.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (03):
  • [47] Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline
    Binetti, G
    Locascio, JJ
    Corkin, S
    Vonsattel, JP
    Growdon, JH
    ARCHIVES OF NEUROLOGY, 2000, 57 (02) : 225 - 232
  • [48] Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study
    Livingston, G.
    Walker, A. E.
    Katona, C. L. E.
    Cooper, C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01): : 25 - 29
  • [49] The Independence Between Awareness and Cognitive Decline in Alzheimer's Disease
    Dourado, M.
    Sousa, M. F. B.
    Santos, R. L.
    Simoes, P.
    Belfort, T.
    Nogueira, M.
    Dias, R.
    Torres, B.
    Baptista, M. A. T.
    Lacerda, I. B.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [50] Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease
    Duron, E.
    Rigaud, A.
    Lenoir, H.
    Latour, F.
    Seux, M.
    Hanon, O.
    JOURNAL OF NEUROLOGY, 2008, 255 : 126 - 126